Skip to main content

Table 3 The sensitivity of probiotic candidates against 30 antibiotics

From: Functional probiotics of lactic acid bacteria from Hu sheep milk

Types of Drugs

Drug

μg/pill

HSM-1

HSM-10

HSM-14

HSM-18

Penicillins

Penicillin

10 U

39 (S)

39(S)

37(S)

38(S)

Oxacillin

1

27 (S)

19(I)

20(I)

22(S)

Carboxycillin

100

42 (S)

44(S)

33(S)

40(S)

Piperacillin

100

48 (S)

29(S)

37(S)

42(S)

Ampicillin

100

31 (S)

35(S)

31(S)

32(S)

Cephalosporins

Cephalexin

30

33 (S)

40(S)

29(S)

28(S)

Cefazolin

30

47 (S)

25(S)

27(S)

45(S)

Cefradine

30

34 (S)

44(S)

27(S)

32(S)

Ceftazidime

30

28 (S)

44(S)

17(I)

29(S)

Cefoperazone

75

41 (S)

40(S)

29(S)

37(S)

Cefatriaxone

30

41 (S)

38(S)

26(S)

35(S)

Cefuroxime

30

48 (S)

44(S)

36(S)

49(S)

Aminoglycosides

Amikacin

30

19 (I)

19(I)

11(R)

24(S)

Kanamycin

30

25 (S)

21(S)

7(R)

20(I)

Neomycin

30

22 (S)

17(I)

15(R)

20(I)

Gentamicin

10

22 (S)

14(R)

12(R)

21(S)

Tetracycline

Tetracycline

30

14 (R)

13(R)

29(S)

14(R)

Doxycycline

30

22 (S)

22(S)

28(S)

17(I)

Minocycline

30

30 (S)

27(S)

35(S)

26(S)

Macrolides

Erythromycin

15

34 (S)

29(S)

28(S)

32(S)

Midecamycin

30

34 (S)

29(S)

23(S)

26(S)

Glycopeptides

Vancomycin

30

31 (S)

25(S)

7(R)

26(S)

Quinolones

Norfloxacin

10

18 (I)

16(I)

29(S)

25(S)

Ofloxacin

5

32 (S)

27(S)

29(S)

29(S)

Ciprofloxacin

5

27 (S)

26(S)

22(S)

21(S)

Furazolidone

300

23 (S)

17(I)

19(I)

29(S)

Chloramphenicol

30

39 (S)

36(S)

36(S)

36(S)

Clindamycin

2

41 (S)

37(S)

27(S)

40(S)

Sulfonamides

Sulfamethoxazole (SMZ/TMP)â–³

23.75/1.25

17 (I)

18(I)

8(R)

20(I)

Other classes

Polymyxin

300 IU

22 (S)

5(R)

7(R)

24(S)

  1. Note: The zone of inhibition (diameter in mm) for each antibiotic was measured and expressed as susceptible, S (≥21 mm); intermediate, I (16–20 mm), and resistance, R(<=15 mm)